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ABSTRACT 
Sodium valproate has been widely used by man as an antiepileptic drug. Hair loss and curly hair is a rare 
side effect of sodium valproate. We have conducted a prospective clinical study in the Department of 
Neurology in Shafa Hospital, Kerman, Iran for ten years (1994-2004). All 211 epileptic patients in our 
study were given sodium valproate as a single drug treatment. During the course of therapy, all patients 
were strictly monitored every 3 months. Six cases (3.5% of valproate user population) of hair loss and 
curling of hair were found between sodium valproate users. Three cases were female and three were 
male. This side effect observed at least 3 months after its first initial drug therapy. The estimated fre-
quency of curly hair along with hair loss in our study is lower than previously-reported frequencies (6-
12%). 
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Epilepsy is a common, chronic, and often disabling 
condition, and effective treatment often requires long-
time pharmacotherapy [ 1,  2]. Sodium valproate is very 
effective against absence seizures, but it’s not the drug 
of choice. It is preferred in the patient with concomitant 
generalized tonic-clonic attacks. Valproate is unique in 
its ability to control certain types of myoclonic seizures; 
in some cases the effect is very dramatic. The drug is 
effective in generalized tonic-clonic seizures, especially 
those that are primarily generalized. A few patients with 
atonic attacks may also respond, some evidence sug-
gests that the drug is effective in partial seizures [ 3]. 
The clinical utility of the drug may be compromised 
by its adverse effects such as tremor, weight gain, hair 
loss and gastrointestinal disturbances like nausea, vom-
iting, abdominal pain and heart burn. But the mean 
highlight to be tackle in this article is hair loss and curly 
hair as a side effect of sodium valproate [ 4- 19]. Curly 
hair associated with hair loss is uncommon side effect 
of sodium valproate. Due to its unusual report, a very 
few studies have been conducted. However, a review of 
reports published over 30 years revealed 643 cases that 
developed valproate-associated hair loss [ 15]. This 
study aims to evaluate the frequency of hair loss in epi-
leptic patients using sodium valproate. 
MATERIALS AND METHODS 
This is a prospective clinical study on patients who 
used sodium valproate for 10 years in the Department of 
Neurology, Shafa Hospital, Kerman, Iran (1994-2004). 
All the 211 epileptic patients have been taking up so-
dium valproate as a single agent. During the course of 
therapy, all patients were strictly monitored every 3 
months. Sodium valproate was started at lowest thera-
peutic dose. The dose was gradually increased to avoid 
some undesirable adverse effect. Appropriate dose was 
selected based on the lowest dose disappearing epileptic 
attack. All patients were examined for hair abnormality 
and when found, therapeutic plan was changed to an-
other anticonvulsant drug. The term “diffuse hair loss” 
has been used in patients with more than 40% reduction 
in scalp hair. 
RESULTS 
Among 211 patients who received sodium valproate 
(enteric coated tablet), 51% were male and 49% were 
female (no significant difference). Patients’ mean age of 
epilepsy onset was 11 years old and mean age starting to 
receive sodium valproate was18 years old. More than 
78% of patients had experienced tonic–clonic seizures 
(primary or secondary). All patients received monother-
apy (single drug treatment). Overall, there were 6 cases 
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(3.5%) of hair loss and curling of hair. Among them 3 
cases were female and 3 were male. This side effect 
could be observed 3 months after first dose of therapy. 
It took 1-2 years before appearance of hair loss and 
curly hair in other cases. The original and normal tex-
ture of hair appeared after discontinuance of sodium 
valproate. In six cases of hair loss and curling hair, 
mean age was 8 years old. The types of epilepsy in 3 out 
of 6 cases were generalized tonic-clonic and in remain-
ing 3 cases were atypical petit mal seizures. 
DISCUSSION 
Curly hair associated with hair loss is uncommon 
side effect of sodium valproate. Due to its unusual re-
port, a very few studies have been conducted. In 1977, 
Jeavons and co-workers did a study on a group who 
used sodium valproate. They observed that 5 out of 295 
patients who were using sodium valproate experienced 
curling of hair [ 4]. Another incidence of hair loss and 
curling of hair was reported in a patient who received up 
to 3 grams sodium valproate daily for 30 months. Nine 
months after discontinuing the drug, her hair started to 
revert to its former straight style [ 8]. In a comparison 
between sodium valproate and carbamazepine for the 
treatment of generalized tonic-clonic seizures, Mattson 
and colleagues found that 12% of patients using val-
proate had experienced hair loss or change in texture 
[ 12]. In a recent study, hair loss has been reported in 7-
8% of patients receiving divalproex (a unique combina-
tion of equal proportions of sodium valproate and val-
proic acid, which dissociates in the gastrointestinal tract 
into the active valproate ion) [ 18]. 
Based on our study, 6 out of 211 epileptic patients 
(3.5%) experienced hair loss and curling of hair. Our 
results indicate that the mean age of patients with hair 
loss is lower than those do not show this side effect. The 
patients also experienced graying and dirty appearance 
of hair associated with alopecia. Herrans and his co-
worker reported discoloration of hair due to sodium 
valproate therapy [ 20]. Zinc deficiency was also re-
ported among the patient who received a total dose of 
50mg/kg weight daily. Very high dose and long time of 
sodium valproate could be a causative agent for zinc 
deficiency. In any case, there is no strong evidence to 
correlate zinc deficiency and curling of hair to sodium 
valproate [ 8]. On the other hand, we should also con-
sider some physiologic factors that affect the patients. 
Many drugs can cause hair loss but acquired tempo-
rary curly hair due to sodium valproate is a rare finding 
[ 14]. Compounds containing thallium, lithium and anti-
coagulants can induce hair loss. Some dermatologic 
disorders such as transient rashes and stomatitis can be 
observed as well [ 14]. One case of generalized morphea 
has also been reported [ 5]. 
Kinking of the scalp hair is probably synonymous 
with the whisker hair that has been reported in some 
cases [ 21]. Also, it may be confused with the wooly hair 
nevus, but acquired progression of kinky scalp hair is 
clinically different based on its onset in adolescence or 
adult life and its progressive extension over period of 
years [ 9]. 
Sodium valproate can be used in the treatment of 
other neurological disorders rather than epilepsy. It may 
be administered for patients with bipolar disorders [ 22]. 
Most side effects of the drugs have been reported in 
patients with epilepsy. It would be interesting to com-
pare the side effects of sodium valproate in various dis-
orders. Also, it is interesting to see the effect of the drug 
on animals. One study has reported sodium valproate-
induced hair loss in cats [ 23]. 
Based on current study, sodium valproate can cause 
hair loss and curliness but this is a reversible side effect. 
The derangement can be observed 3 months after start-
ing dose or later. But in some cases it takes 1 year or 2 
years before hair loss and curly hair appears. Younger 
patient have higher incidence of hair loss and curling. 
The original and normal texture of hair will appear after 
discontinuance of sodium valproate. 
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